elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28213564-0E23FF2E-3226-4910-9448-825C3D7C636A
Q28213564-0E23FF2E-3226-4910-9448-825C3D7C636A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28213564-0E23FF2E-3226-4910-9448-825C3D7C636A
Evaluation of bleeding complications associated with glycoprotein IIb/IIIa inhibitors
P2860
Q28213564-0E23FF2E-3226-4910-9448-825C3D7C636A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28213564-0E23FF2E-3226-4910-9448-825C3D7C636A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9716a0b1e3d5e98123201dc8c6c1110ce2f8c14e
P2860
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.